[Acute tumor lysis syndrome due to mono-therapy with a corticosteroid in a patient with non-Hodgkin lymphoma]

Ned Tijdschr Geneeskd. 1997 Aug 16;141(33):1621-3.
[Article in Dutch]

Abstract

A 20-year-old man was hospitalised because he nearly suffocated when lying on his back. After bronchoscopy which revealed severe external compression of the airways, suddenly respiratory insufficiency developed. Because a malignant lymphoma was suspected chemotherapy was started, using monotherapy with prednisolone as the risk of acute tumour lysis syndrome (ATLS) is high with polychemotherapy of bulky tumours. Nevertheless ATLS developed, for which haemodialysis had to be applied. The tumour, a T-cell lymphoblastic non-Hodgkin lymphoma with high grade malignancy, was treated successfully with cyclophosphamide, doxorubicin, vincristine en prednisone. ATLS is characterized by hyperkalaemia, hyperuricaemia, hyperphosphataemia, hypocalcaemia, lactate acidosis and acute renal failure. It can occur in the course of aggressive cytoreductive therapy in rapidly growing lymphoproliferative malignancies with large tumour size, due to massive tumour cel lysis. Corticosteroid monotherapy is a very rare cause of ATLS.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acute Disease
  • Adult
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Lymphoma, T-Cell / complications
  • Lymphoma, T-Cell / drug therapy*
  • Male
  • Prednisolone / adverse effects*
  • Renal Dialysis
  • Superior Vena Cava Syndrome / etiology
  • Thoracic Neoplasms / complications
  • Thoracic Neoplasms / drug therapy*
  • Tumor Lysis Syndrome / etiology*
  • Tumor Lysis Syndrome / therapy

Substances

  • Antineoplastic Agents, Hormonal
  • Prednisolone